13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-09-02 Event 2025-09-02 SEC 0000919574-25-005433 →

BROADWOOD PARTNERS, L.P. STAAR SURGICAL CO STAA

Stake: 27.30% Shares: 13,545,391 CUSIP: 852312305 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

On August 5, 2025, the Issuer announced that it had entered into a definitive merger agreement through which Alcon will acquire the Issuer. The Reporting Persons presently intend to vote against the merger and have issued a press release on this topic today that is attached as Exhibit B. The Reporting Persons also continue to explore strategic alternatives to the merger, including through contact with possible alternative strategic and financial partners for the Issuer. The Reporting Persons intend to review their investment in the Issuer on a continuing basis, taking into account the merger agreement. Depending on various factors including, without limitation, the Issuer's financial position, the terms of the merger agreement, a potential superior offer, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may take such actions with respect to their investment in the Issuer as they deem appropriate. In that regard, the Reporting Persons have been and may continue to be in contact with members of the Issuer's management, Board, other significant shareholders, potential alternative strategic and financial partners for the Issuer, and others regarding alternatives that could be employed to create additional shareholder value, whether in the near or long term. Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market or privately negotiated transactions, on such terms and at such times as the Reporting Persons may deem advisable.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
12 13D/G filings on this issuer
11 other filings besides this one
Filer Track Record
22 filings by this filer
21 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 5.63
7,730,427 shares short · +10.2% vs prior

Other 13D/G Filings on STAAR SURGICAL CO

FiledFormFilerStakeShares
2026-01-08 SCHEDULE Yunqi Capital Ltd 6.50% 3,257,130 view →
2025-11-03 SCHEDULE Yunqi Capital Ltd 5.10% 2,500,061 view →
2025-09-26 SCHEDULE BROADWOOD PARTNERS, L.P. 27.40% 13,545,391 view →
2025-04-02 SCHEDULE BROADWOOD PARTNERS, L.P. 25.40% 12,512,944 view →
2025-03-03 SCHEDULE BROADWOOD PARTNERS, L.P. 24.30% 11,979,098 view →
2024-01-10 SC BROADWOOD PARTNERS, L.P. view →
2023-10-10 SC BROADWOOD PARTNERS, L.P. view →
2021-10-01 SC BROADWOOD PARTNERS, L.P. view →
2021-06-16 SC BROADWOOD PARTNERS, L.P. view →
2021-04-05 SC BROADWOOD PARTNERS, L.P. view →
2020-08-12 SC BROADWOOD PARTNERS, L.P. view →

Other Filings by BROADWOOD PARTNERS, L.P.

FiledFormIssuerStakeShares
2025-09-26 SCHEDULE STAAR SURGICAL CO STAA 27.40% 13,545,391 view →
2025-04-02 SCHEDULE STAAR SURGICAL CO STAA 25.40% 12,512,944 view →
2025-03-03 SCHEDULE STAAR SURGICAL CO STAA 24.30% 11,979,098 view →
2025-02-10 SCHEDULE Oncocyte Corp IMDX 40.20% 11,560,350 view →
2025-01-28 SCHEDULE Lineage Cell Therapeutics, Inc. LCTX 24.50% 57,848,357 view →
2024-01-10 SC STAAR SURGICAL CO STAA view →
2023-10-10 SC STAAR SURGICAL CO STAA view →
2022-04-15 SC Oncocyte Corp IMDX view →
2021-10-01 SC STAAR SURGICAL CO STAA view →
2021-09-24 SC Oncocyte Corp IMDX view →
2021-06-16 SC STAAR SURGICAL CO STAA view →
2021-04-05 SC STAAR SURGICAL CO STAA view →
2021-03-16 SC Lineage Cell Therapeutics, Inc. LCTX view →
2021-02-09 SC OncoCyte Corp IMDX view →
2021-01-22 SC OncoCyte Corp IMDX view →
2020-08-12 SC STAAR SURGICAL CO STAA view →
2019-09-13 SC OncoCyte Corp IMDX view →
2019-07-02 SC OncoCyte Corp IMDX view →
2019-03-12 SC Asterias Biotherapeutics, Inc. view →
2019-03-12 SC BIOTIME INC LCTX view →
Showing 20 of 21

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →